Evidence map›Paper›PMID 42120426›Full record

ArticleNature communications2026

Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation.

Lian Cui, Hengli Lu, Jiangluyi Cai, Ying Li, Zeyu Chen, Yiwei Zhang, Bingjie Li, Yuanyuan Wang, Nan Yang, Lingling Yao and 14 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Lian Cui *Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0003-0997-6424
Hengli Lu *Department of Orthopedic Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiangluyi Cai *Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Ying Li *Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0002-4041-2646
Zeyu ChenDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Yiwei ZhangSchool of Medicine, Tongji University, Shanghai, China.ORCID http://orcid.org/0000-0002-2329-588X
Bingjie LiShanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0000-0002-4871-7444
Yuanyuan WangDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Nan YangDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Lingling YaoDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Rui MaDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Xin WangDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Yingyuan YuDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Dawei HuangDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0003-0732-1467
Peiyao ZhuDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Hao MeiInstitute of Psoriasis, Tongji University School of Medicine, Shanghai, China.
Qianyu ChenDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Yu ZhuangDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Yunlu GaoDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Ning YuDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Lingjuan ZhangState Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.ORCID http://orcid.org/0000-0001-6937-4578
Chunyuan GuoDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China. chunyuanguo@aliyun.com.ORCID http://orcid.org/0000-0001-6769-1713
Huijing XiangSchool of Life Sciences, Shanghai University, Shanghai, China. xianghuijing@shu.edu.cn.ORCID http://orcid.org/0000-0002-7465-3392
Yuling ShiDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China. shiyuling1973@tongji.edu.cn.ORCID http://orcid.org/0000-0002-1273-7881

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82273525National Natural Science Foundation of China (National Science Foundation of China) 82430101National Natural Science Foundation of China (National Science Foundation of China) 825B2098National Natural Science Foundation of China (National Science Foundation of China) T2322018
6 · The paper itself

Abstract

Double-stranded RNA (dsRNA) and reactive oxygen species (ROS) contribute to the exacerbation of skin inflammatory diseases such as psoriasis and atopic dermatitis. While antioxidant strategies have been extensively explored, approaches to neutralize pathogenic dsRNA remain limited. Here, we show that Mo

Indexed as

Reactive Oxygen SpeciesRNA, Double-StrandedAnimalsCeriumFemaleHumansInflammationInterferon Type IMethotrexateMiceNanoparticlesPolyoxometalatesSkinCeriumInterferon Type IMethotrexatePolyoxometalatesReactive Oxygen SpeciesRNA, Double-Stranded

Identifiers

PMID42120426
PMCPMC13385762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.